Results 1 to 6 of 6

Thread: Vaccine for kidney and bowel cancers 'within three years'

  1. #1
    Join Date
    Feb 2005
    Location
    USA
    Posts
    4,740

    Vaccine for kidney and bowel cancers 'within three years'

    This is a huge development.

    Vaccine for kidney and bowel cancers 'within three years'
    Dailymail
    Nov.14, 2006
    A revolutionary cancer vaccine developed by UK scientists can destroy and shrink deadly tumours by using the body's own immune system, it has emerged.

    In trials the jab has surpassed expectations, sparking hopes it could prove an effective treatment for cancers that strike tens of thousands of Britons each year.

    One patient given the vaccine has seen his tumour disappear completely for more than six months.

    Another two have seen their tumours shrink, and in three people the cancer has been halted in its tracks.

    The researchers said results were 'exciting' and 'very encouraging'.

    Oxford BioMedica, the British company behind the jab, is initially hoping it will provide a new treatment for kidney and bowel cancer.

    Between them these cause 40,000 new cases and 20,000 deaths each year in the UK.

    To date 150 patients have had the vaccine and 95 per cent of those that can be evaluated have had an 'anti-tumour response'.

    If further trials prove successful, the vaccine could be licensed for use against kidney cancer within just three years.

    Experts last night said the data suggests the 'gene therapy' vaccine could prove an effective treatment for a whole range of cancers. The new jab called TroVax works in a totally different way to existing treatments by harnessing the patient's own immune system to fight the disease.

    The patient is given a series of injections in the arm containing a harmless virus and a gene for a protein called 5T4.

    This protein is found on the surface of tumours but not on healthy cells.

    By injecting the gene into the body, it triggers an immune system reaction which kills the cancer cells but leaves healthy tissue unharmed.

    Data from an early trial involving 34 people with kidney cancer were revealed at a major American cancer conference earlier this year. Last week updated data was announced at a medical conference in Prague from the Phase II trial, in which people with renal cell carcinoma had the vaccine on its own or in combination with other standard treatments.

    Renal cell carcinoma is a particularly aggressive form of kidney cancer which accounts for more than 80 per cent of the 6,000 cases of kidney cancer diagnosed each year in the UK and claims 3,400 lives annually.

    Among the 18 given the treatment along with a drug called interleukin-2, one patient saw his tumour totally disappear.

    Two patients have seen it reduce in size - one to the point where it can no longer be seen in his latest scan.

    In another three their disease has been stable for more than three months with one patient finding his disease has halted for more than 46 weeks.

    Dr Bob Amato, who led the US trials, said the trial was primarily designed to show the vaccine was safe and produced an immune system reaction.

    To see that it was also helping shrink or halt the growth of tumours in some patients was an unexpected bonus.

    'To find we are already seeing this kind of activity when it is not the primary objective makes it exciting,' he said.

    'In some cases we have seen very significant responses.'

    Among the kidney cancer patients, the vaccine only appears to work for the most common type known as 'clear cell renal cell carcinoma'. Those with a form known as 'papillary renal cell carcinoma' did not respond to the treatment during the trials.

    The studies are still at an early stage and the latest results have not yet been published in a peer-reviewed journal.

    But based on their success, a much larger study involving 700 patients around the world including dozens from the UK with this kind of kidney cancer is now being launched.

    All patients will have had surgery to remove the tumour and they will then receive the jab, or a placebo, alongside with three different standard drug treatments.

    Professor Robert Hawkins who is now starting the latest phase of trials at the Christie Hospital in Manchester, said the data from the phase II trials was 'very encouraging.'

    'It would be rare that a patient would get rid of a tumour with standard treatment,' he said. 'The fact it has happened in a relatively small trial is encouraging.

    'We hope this treatment will improve the outcome of patients and that is why we need larger trials with hundreds to prove whether this combination is better than existing treatments and causes no unexpected side effects.'

    Dr Daljit Kaur, clinical trials research manager at Cancer Research UK, said TroVax developed out of original research by Manchester scientists who were funded by the charity.

    'The data so far suggests TroVax could be an effective treatment for several types of cancer, including kidney cancer, which affects more than 6,600 people each year in the UK,' he said.

    Oxford BioMedica was established in 1995 as a spin-out from Oxford University and specialises in the development of gene-based treatments.

  2. #2
    Join Date
    Aug 2005
    Location
    Pride Fighting nuthugger
    Posts
    2,378
    Logan13 this is great news my friend, i am surrounded by cancer.

    My fahter passed away from colon cancer, our family cat 15 years old passed away from colon cancer go figure same cancer has my father.

    My coworker and friend 43 years old has a cancer growth on is colon, he now needs to get more test done to see where the cancer is at, sad sad sad.

    You made my day by providing this great news. Its time we start winning the war against this terrible disease, they say that 1 in 3 people will have a cancer one day, very scary.

  3. #3
    Join Date
    Nov 2005
    Location
    Tampa,Montreal,Paris
    Posts
    4,186
    Colon cancer is one of the deadliest forms of cancers in the world. Yet it can be easily prevented and treated albeit patient neglected it. Colonoscopies and endoscopies.Poloys and Biopsies taken for tests. One of the reasons is that it is perhaps the least pleasant of tests to take, yet sedative drugs can be taken.

  4. #4
    Join Date
    Aug 2005
    Location
    Pride Fighting nuthugger
    Posts
    2,378
    I know i had my first colonoscopy in October at the age of 34, they found nothing, the drugs they give you knock you out so you almost fall asleep during the test.

  5. #5
    Join Date
    Feb 2005
    Location
    USA
    Posts
    4,740
    Quote Originally Posted by sonar1234
    I know i had my first colonoscopy in October at the age of 34, they found nothing, the drugs they give you knock you out so you almost fall asleep during the test.
    I am due for my first one, my younger brother had one in Sept. I am afraid that I will just put it off.......

  6. #6
    Join Date
    Dec 2003
    Location
    Chicago/Israel
    Posts
    946
    There is no down side to this story......So I shot my bbgun in the air

Thread Information

Users Browsing this Thread

There are currently 1 users browsing this thread. (0 members and 1 guests)

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •